Neu auf wallstreet:online? Jetzt kostenlos registrieren!
Registrieren | Login
x
Benutzername:

Passwort:

Angemeldet bleiben
Passwort vergessen?

    Genta - Revolution in der Krebstherapie? (Seite 5493)

    eröffnet am 20.08.06 00:07:01 von
    Macrocosmonaut [Blogger]

    neuester Beitrag 05.03.14 13:45:53 von
    DonJohn93
    Beiträge: 55.414
    ID: 1.077.896
    Aufrufe heute: 6
    Gesamt: 4.978.267

    29.08.13
    0,0001
    $
    0,00 $
    0,00 %

    Beitrag schreiben Ansicht: Normal
    Avatar
    Scania01
    schrieb am 10.05.12 15:42:10
    Beitrag Nr. 54.921 (43.147.655)
    Antwort auf Beitrag Nr.: 43.147.010 von hoffihoff am 10.05.12 13:48:45ja, die Shorties sind eben nicht mehr da und ein tieferer Wandlungspreis unter
    den Nennwert geht auch nicht. Was nun?????????????????????????????
    Verkehrte Welt!!!!!!!!!!!!!!!!!!!:cool:
    Avatar
    hoffihoff
    schrieb am 10.05.12 22:46:47
    Beitrag Nr. 54.922 (43.149.950)
    Antwort auf Beitrag Nr.: 43.147.655 von Scania01 am 10.05.12 15:42:10Welchen Nennwert meinst du :confused: ?

    Genta steht aktuell bei 0.0011 USD und der Kurs kann noch bis auf 0.0001 USD fallen !

    Mittlerweile könnte man den Wandelkurs der Optionen auf 0.0003 USD nach unten angepasst haben und mit 200 - 300% Gewinn abverkaufen !
    Avatar
    wkndealer
    schrieb am 11.05.12 11:26:12
    Beitrag Nr. 54.923 (43.151.945)
    Ihr wollt das der Kurs steigt? Dann müsste ich ja alle Aktien verkaufen... :(

    ...Kurse steigen nämlich immer, wenn ich verkaufe. ;)

    Der ganze Commerzbank Vorstand bekniet mich auch schon täglich.. :D
    Avatar
    Expertchen007
    schrieb am 14.05.12 15:15:50
    Beitrag Nr. 54.924 (43.162.268)
    Euch muss man aber auch alles liefern....seit so Börsianer hier:



    http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=861221…


    Genta Incorporated Reports First Quarter 2012 Financial Results
    BERKELEY HEIGHTS, NJ – May 14, 2012


    Genta Incorporated (GNTA) today reported results for the quarter ended March 31, 2012. For
    the first quarter of 2012, the Company reported net income of $5.2 million, or $0.00 net income per basic and diluted share, compared with net
    income of $0.5 million, or $0.03 net income per basic share and $0.00 net income per diluted share, for the first quarter of 2011. As of May 11,
    2012, the Company has approximately 2.4 billion outstanding shares of common stock.
    The financial results reported today reflect a number of considerations, some of which are noted below, and all of which will be reported in the
    Company’s Report on Form 10-Q. As previously reported, in March 2012, the Company issued convertible notes totaling $2.25 million and
    redeemed certain notes that had been issued in September 2011, having a face value of $8.4 million. The redemption of those notes resulted in a
    loss of $8.2 million recorded in the first quarter of 2012.
    As part of a financing transaction in September 2011, the Company issued a series of warrants to purchase shares of common stock in exchange
    for extending the maturity of certain convertible notes and issued debt warrants to purchase additional convertible notes. Similarly, in December
    2010 and March 2010, the Company issued a series of warrants to purchase shares of common stock in exchange for extending the maturity of
    certain convertible notes. All of these warrants and the debt warrants have anti-dilution protection and can be exercised using a cashless exercise
    procedure; warrants with these characteristics are accounted for as liabilities and marked-to-market over their lives. At March 31, 2012, the
    warrants and debt warrants were marked-to-market and valued, in total, at $14.7 million, a decline from their valuation at December 31, 2011 of
    $40.2 million, resulting in income of $25.5 million for the three months ended March 31, 2012. In the prior-year period, the decline in valuation
    of the warrants issued in December 2010 and March 2010 resulted in income of $12.7 million for the three months ended March 31, 2011.
    On March 31, 2012, the Company had cash and cash equivalents totaling $2.6 million, compared with $2.1 million at December 31, 2011,
    reflecting the completion of the financing transaction in March 2012 and the receipt of $1.2 million from the sale of portions of the Company’s
    New Jersey net operating losses, mostly offset by the use of funds in operating the Company. Net cash used in operating activities for the three
    months ended March 31, 2012 was $1.3 million, reflecting the receipt of $1.2 million from the sale of the tax losses. Average net monthly cash
    outflow is projected to be approximately $1.0 million during the first half of 2012.
    Avatar
    Scania01
    schrieb am 14.05.12 15:46:22
    Beitrag Nr. 54.925 (43.162.432)
    Antwort auf Beitrag Nr.: 43.162.268 von Expertchen007 am 14.05.12 15:15:50Ach bist du nett das du uns in deinen Interesse die Zahlen hier präsentierst.
    Sehen gar nicht mal so schlecht aus, 5 Millionen Nettogewinn.
    Da bleibe ich doch glatt dabei.:lick:
    Avatar
    auriga
    schrieb am 15.05.12 07:47:58
    Beitrag Nr. 54.926 (43.165.010)
    Antwort auf Beitrag Nr.: 43.162.268 von Expertchen007 am 14.05.12 15:15:506. Convertible Notes and Warrants

    On March 28, 2012, the Company entered into a securities purchase agreement with certain investors, pursuant to which it agreed to issue up to $13.5 million of 6.0% senior secured convertible promissory notes due March 30, 2022, (the “March 2012 I Notes”), convertible into shares of common stock, at an initial conversion rate of 100,000 shares of common stock for every $100 of principal and accrued interest due under the notes. The issuance of the March 2012 I Notes is referred to herein as the “March 2012 Financing.”

    The Company closed on $2.0 million of March 2012 I Notes on March 30, 2012. In addition, the Company and certain holders of the June 2008 Notes (described below) agreed to exchange approximately $2.0 million of June 2008 Notes for $250 thousand of March 2012 I Notes. The receipt of the remaining $11.25 million of gross proceeds is subject to the purchasers exercising their option, at each purchaser’s discretion, to purchase up to each purchaser’s pro rata portion of an additional $11.25 million principal amount of March 2012 I Notes, which such option is exercisable for a period of five years from the closing.

    The March 2012 I Notes bear interest at a rate of 6% per annum, payable semi-annually in additional March 2012 I Notes, and may not be prepaid by the Company. The March 2012 I Notes have a ten-year term; however, the holder of each March 2012 I Note has the right to require the Company to repay 100% of the outstanding principal and accrued interest on each note on or after March 30, 2013. The March 2012 I Notes are classified as a short-term liability due to this right of redemption. The March 2012 I Notes are convertible into shares of the Company’s common stock at a conversion rate of 100,000 shares of common stock for every $100.00 of principal and interest being converted. The March 2012 I Notes are secured with a first priority lien on substantially all of the assets of the Company, which lien is pari passu with the security interest underlying the September 2011 G Notes and September 2011 H Notes, which are defined below.

    In connection with the March 2012 Financing, the Company and certain holders of its existing convertible notes entered into an agreement, which, among other things, provided for the following: (A) predetermined conversion price adjustment provisions that had been established with the September 2011 Financing, (defined below), were deleted, (B) the requirement for the Company to effect a reverse stock split, that had been part of the September 2011 Financing, was deleted, (C) the holders of existing convertible notes agreed to amend the put rights of such existing convertible notes, currently effective starting on March 31, 2012, to require the approval of certain requisite holders (as defined therein) and (D) the Company agreed to distribute the proceeds held in the blocked account resulting from the September 2011 Financing to holders of the September 2011 H Notes and to redeem an equal amount of September 2011 H Notes at face value. The redemption of the September 2011 H Notes resulted in a loss of $8.2 million for the three-month period ended March 31, 2012, which represents the difference between the face amount of the notes redeemed and their carrying amount on the date of redemption.

    When the March 2012 I Notes were issued, the aggregate intrinsic value of the difference between the market price of the Company’s share of stock on March 30, 2012 and the conversion price of the March 2012 I Notes was in excess of the face value of the $2.25 million March 2012 I Notes, and thus, a full debt discount was recorded in an amount equal to the face value of the debt. The Company is amortizing the resultant debt discount over the term of the March 2012 I Notes through their maturity date.

    http://www.sec.gov/Archives/edgar/data/880643/00014377491200…
    Avatar
    Boersenbeate
    schrieb am 15.05.12 11:09:06
    Beitrag Nr. 54.927 (43.166.080)
    Antwort auf Beitrag Nr.: 43.165.010 von auriga am 15.05.12 07:47:58Interessant, diesen Beitrag noch zu lesen.

    Insbesondere der Teil:
    ... In connection with the March 2012 Financing, the Company and certain holders of its existing convertible notes entered into an agreement, which, among other things, provided for the following: (A) predetermined conversion price adjustment provisions that had been established with the September 2011 Financing, (defined below), were deleted, (B) the requirement for the Company to effect a reverse stock split, that had been part of the September 2011 Financing, was deleted, (C) the holders of existing convertible notes agreed to amend the put rights of such existing convertible notes, currently effective starting on March 31, 2012, to require the approval of certain requisite holders (as defined therein) and (D) the Company agreed to distribute the proceeds held in the blocked account resulting from the September 2011 Financing to holders of the September 2011 H Notes and to redeem an equal amount of September 2011 H Notes at face value....
    Avatar
    auriga
    schrieb am 15.05.12 12:49:23
    Beitrag Nr. 54.928 (43.166.641)
    Antwort auf Beitrag Nr.: 43.166.080 von Boersenbeate am 15.05.12 11:09:06Ja, insbesondere ( A) und (B) sind auch im Zusammenhang zu lesen denke ich mal..... predetermined conversion price adjustment provisions that had been established with the September 2011 Financing, (defined below), were deleted.....vorher festgelegte Klauseln(Regelungen) über Wandelpreis-Anpassungen wurden aufgehoben.....und.......the requirement for the Company to effect a reverse stock split, that had been part of the September 2011 Financing, was deleted..........die Forderung an Genta einen R/S durchzuführen ruht ebenfalls.
    Avatar
    Boersenbeate
    schrieb am 15.05.12 20:48:22
    Beitrag Nr. 54.929 (43.169.447)
    Antwort auf Beitrag Nr.: 43.166.641 von auriga am 15.05.12 12:49:23Das finde ich in jedem Falle eine gute Entwicklung. Aber es gibt trotzdem den Vorratsbeschluss vom Dezember 2011 (somit nach dem zitierten Filing gemacht) zur Durchführung von 2 R/S. Ob sie tasächlich notwenig sind, und auch der Vorratsbeschluss damit hinfällig wird, wird sich zeigen.
    Avatar
    auriga
    schrieb am 16.05.12 00:20:54
    Beitrag Nr. 54.930 (43.170.372)
    Antwort auf Beitrag Nr.: 43.169.447 von Boersenbeate am 15.05.12 20:48:22Ich weiß jetzt nicht genau was du meinst.....mein Zirat ist aus dem 10Q von gestern(MO)




    Beitrag zu dieser Diskussion schreiben

    Investoren, die diesen Wert beobachten, informieren sich auch über:

    WertpapierPerf. %
    +4,52
    +0,18
    +12,39
    +8,77
    +0,66
    -11,76
    0,00
    0,00
    0,00
    +1,05